Insufficient scRNA-seq data for expression of NANOS3 at single-cell level.
Insufficient scRNA-seq data for expression of NANOS3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 212.66 | 2635 / 2642 | 100% | 13.33 | 704 / 705 |
thymus | 55% | 13.39 | 356 / 653 | 91% | 3.86 | 553 / 605 |
ovary | 39% | 9.73 | 71 / 180 | 90% | 3.96 | 388 / 430 |
intestine | 33% | 8.17 | 318 / 966 | 71% | 5.53 | 374 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.22 | 1 / 1 |
prostate | 59% | 16.31 | 145 / 245 | 39% | 0.85 | 197 / 502 |
pancreas | 9% | 1.70 | 29 / 328 | 78% | 2.48 | 139 / 178 |
stomach | 14% | 3.38 | 51 / 359 | 72% | 5.67 | 206 / 286 |
breast | 22% | 4.87 | 103 / 459 | 60% | 1.64 | 666 / 1118 |
bladder | 14% | 3.52 | 3 / 21 | 68% | 3.54 | 341 / 504 |
esophagus | 31% | 7.86 | 450 / 1445 | 48% | 2.18 | 87 / 183 |
uterus | 19% | 4.36 | 32 / 170 | 56% | 1.80 | 255 / 459 |
adrenal gland | 9% | 2.00 | 22 / 258 | 63% | 2.95 | 145 / 230 |
lung | 24% | 5.45 | 137 / 578 | 46% | 1.39 | 531 / 1155 |
heart | 53% | 13.44 | 456 / 861 | 0% | 0 | 0 / 0 |
skin | 7% | 1.30 | 125 / 1809 | 31% | 0.81 | 147 / 472 |
kidney | 12% | 3.09 | 11 / 89 | 25% | 0.48 | 222 / 901 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.75 | 16 / 45 |
blood vessel | 29% | 6.67 | 387 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.54 | 8 / 29 |
peripheral blood | 12% | 3.27 | 110 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.14 | 8 / 80 |
liver | 0% | 0 | 0 / 226 | 9% | 0.20 | 38 / 406 |
adipose | 7% | 1.30 | 84 / 1204 | 0% | 0 | 0 / 0 |
spleen | 4% | 0.85 | 10 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.21 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0007283 | Biological process | spermatogenesis |
GO_0061157 | Biological process | mRNA destabilization |
GO_0006417 | Biological process | regulation of translation |
GO_0007281 | Biological process | germ cell development |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0048477 | Biological process | oogenesis |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0017148 | Biological process | negative regulation of translation |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NANOS3 |
Protein name | Nanos homolog 3 (NOS-3) |
Synonyms | NOS3 |
Description | FUNCTION: Plays a role in the maintenance of the undifferentiated state of germ cells regulating the spermatogonia cell cycle and inducing a prolonged transit in G1 phase. Affects cell proliferation probably by repressing translation of specific mRNAs. Maintains the germ cell lineage by suppressing both Bax-dependent and -independent apoptotic pathways. Essential in the early stage embryo to protect the migrating primordial germ cells (PGCs) from apoptosis. . |
Accessions | ENST00000673200.1 [P60323-2] ENST00000339133.6 [P60323-2] P60323 ENST00000672749.1 [P60323-1] ENST00000397555.3 [P60323-1] |